After the U.S. Food and Drug Administration learned about potentially fraudulent work done on behalf of pharmaceutical companies by a contract research firm in Texas, they didn’t pull the drugs off the market. You might think, though, that they might hold off on approving new drugs based on testing that came from that lab. You would be wrong. [More]
